Dr. Öğr. Üyesi SİNAN ÖZER

Yayın Ağı

Makaleler 5

1. Development of Nanofiber Patch Formulation Containing Rutin Hydrate, In Vitro and In Vivo Evaluation

ÖZER S., AKYIL E., ARSLAN R., ARI N. S.

ACS OMEGA , cilt.10, sa.27, ss.29037-29058, 2025 (SCI-Expanded, Scopus)

2. The Usage of PEG in Drug Delivery Systems- A Mini Review

ÖZER S., AKYIL E.

Polymer Science: Peer Review Journal , cilt.3, sa.4, 2022 (Hakemli Dergi)

3. Moxifloxacin Hydrochloride-Loaded Eudragit (R) RL 100 and Kollidon (R) SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity

YURTDAŞ KIRIMLIOĞLU G., ÖZER S., BÜYÜKKÖROĞLU G., Yazan Y.

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , cilt.24, sa.3, ss.328-341, 2021 (SCI-Expanded, Scopus)

4. Preparation and in vitro evaluation of in situ gelling system containing lithium carbonate for parenteral administration

ÖZER S., ŞENEL B., Yazan Y.

POLYMER BULLETIN , cilt.77, sa.2, ss.599-622, 2020 (SCI-Expanded, Scopus)

5. Formulation and In Vitro Evaluation of Moxifloxacin Hydrochloride-Loaded Polymeric Nanoparticles for Ocular Application

YURTDAŞ KIRIMLIOĞLU G., ÖZER S., BÜYÜKKÖROĞLU G., Yazan Y.

LATIN AMERICAN JOURNAL OF PHARMACY , cilt.37, sa.9, ss.1850-1862, 2018 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 10

1. DEVELOPMENT AND IN VITRO, IN VIVO EVALUATION OF RUTIN HYDRATE LOADED EUDRAGIT® L100 NANOFIBER PATCH

ÖZER S., AKYIL E., ARSLAN R.

IPTS 2024 - 21st International Pharmaceutical Technology Symposium, Ankara, Türkiye, 9 - 11 Eylül 2024, (Tam Metin Bildiri)

2. SILDENAFIL-LOADED NANOFIBERS FOR BUCCAL DELIVERY

DOĞAN N., ÖZER S., ARPA M. D., AKYIL E., BAŞARAN E.

IPTS 2024 - 21st International Pharmaceutical Technology Symposium, Ankara, Türkiye, 9 - 11 Eylül 2024, (Tam Metin Bildiri)

3. Sildenafil-Loaded Nanofibers for Buccal Delıvery

DOĞAN N., ÖZER S., ARPA M. D., BAŞARAN E., AKYIL E.

21st International Pharmaceutical Technology Symposium – IPTS 2024, Ankara, Türkiye, 9 - 11 Eylül 2024, 9 - 11 Eylül 2024, (Tam Metin Bildiri)

4. PHASE SOLUBILITY STUDIES, PREPARATION AND CHARACTERIZATION OF INCLUSION COMPLEXES OF BUTOCONAZOLE NITRATE WITH α-CD AND HP-α-CD.

YURTDAŞ KIRIMLIOĞLU G., ÖZER S., Güleç K., Güleç K.

3. International Gazi Pharma Symposium Series, Ankara, Türkiye, 08 Eylül 2021, (Özet Bildiri)

5. Formulation and in vitro characterization of in situ gelling hydrogel formulations containing levofloxacin hemihydrate loaded nanoparticles

YURTDAŞ KIRIMLIOĞLU G., ÖZER S.

15th Nanoscience and Nanotechnology Conference, Antalya, Türkiye, 3 - 06 Kasım 2019, (Özet Bildiri)

6. IN SITU GELLING SYSTEM CONTAINING LITHIUM CARBONATE FORPARENTERAL ADMINISTRATION

ÖZER S., YAZAN Y.

8th BBBB Conference on Pharmaceutical Sciences, ÇEŞME, Türkiye, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

7. ENTRAPMENT EFFICIENCY AND IN VITRO DISSOLUTION OFDIFFERENT POLYMER-BASED MOXIFLOXACINHYDROCHLORIDE NANOPARTICLES FOR OCULAR DELIVERY

YURTDAŞ KIRIMLIOĞLU G., ÖZER S., YAZAN Y.

2nd International Gazi Pharma Symposium Series, Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

8. PREPARATION AND IN VITRO CHARACTERIZATION OFMOXIFLOXACIN HYDROCHLORIDE-LOADED EUDRAGIT RL®NANOPARTICLES FOR OCULAR DELIVERY

YURTDAŞ KIRIMLIOĞLU G., ÖZER S., YAZAN Y.

2nd International Gazi Pharma Symposium Series, Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

9. FORMULATION AND IN VITRO CHARACTERIZATION STUDIESOF LEVOFLOXACIN HEMIHYDRATE INCORPORATED PLGABASED NANOPARTICLES

YURTDAŞ KIRIMLIOĞLU G., ÖZER S.

2nd International Gazi Pharma Symposium Series, Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

10. DIPYRON-LOADED POLYVINYLPYRROLIDONE (PVP) BASEDPOLYMERIC NANOPARTICLES: FORMULATION AND IN VITROCHARACTERIZATION

Öztürk A. A., Özer S., Yazan Y.

2nd International Gazi Pharma Symposium Series, Ankara, Türkiye, 11 - 13 Ekim 2017, ss.72, (Özet Bildiri)

Metrikler

Dr. Öğr. Üyesi SİNAN ÖZER

Yayınlar & Eserler

1. Development of Nanofiber Patch Formulation Containing Rutin Hydrate, In Vitro and In Vivo Evaluation

2. The Usage of PEG in Drug Delivery Systems- A Mini Review

3. Moxifloxacin Hydrochloride-Loaded Eudragit (R) RL 100 and Kollidon (R) SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity

4. Preparation and in vitro evaluation of in situ gelling system containing lithium carbonate for parenteral administration

5. Formulation and In Vitro Evaluation of Moxifloxacin Hydrochloride-Loaded Polymeric Nanoparticles for Ocular Application

1. DEVELOPMENT AND IN VITRO, IN VIVO EVALUATION OF RUTIN HYDRATE LOADED EUDRAGIT® L100 NANOFIBER PATCH

2. SILDENAFIL-LOADED NANOFIBERS FOR BUCCAL DELIVERY

3. Sildenafil-Loaded Nanofibers for Buccal Delıvery

4. PHASE SOLUBILITY STUDIES, PREPARATION AND CHARACTERIZATION OF INCLUSION COMPLEXES OF BUTOCONAZOLE NITRATE WITH α-CD AND HP-α-CD.

5. Formulation and in vitro characterization of in situ gelling hydrogel formulations containing levofloxacin hemihydrate loaded nanoparticles

6. IN SITU GELLING SYSTEM CONTAINING LITHIUM CARBONATE FORPARENTERAL ADMINISTRATION

7. ENTRAPMENT EFFICIENCY AND IN VITRO DISSOLUTION OFDIFFERENT POLYMER-BASED MOXIFLOXACINHYDROCHLORIDE NANOPARTICLES FOR OCULAR DELIVERY

8. PREPARATION AND IN VITRO CHARACTERIZATION OFMOXIFLOXACIN HYDROCHLORIDE-LOADED EUDRAGIT RL®NANOPARTICLES FOR OCULAR DELIVERY

9. FORMULATION AND IN VITRO CHARACTERIZATION STUDIESOF LEVOFLOXACIN HEMIHYDRATE INCORPORATED PLGABASED NANOPARTICLES

10. DIPYRON-LOADED POLYVINYLPYRROLIDONE (PVP) BASEDPOLYMERIC NANOPARTICLES: FORMULATION AND IN VITROCHARACTERIZATION

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Açık Erişim